Aptus Capital Advisors LLC Makes New Investment in Marsh & McLennan Companies, Inc. $MRSH

Aptus Capital Advisors LLC bought a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 100,882 shares of the financial services provider’s stock, valued at approximately $18,716,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Marsh & McLennan Companies by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 46,589,633 shares of the financial services provider’s stock worth $8,643,309,000 after purchasing an additional 387,100 shares during the last quarter. State Street Corp bought a new stake in Marsh & McLennan Companies during the fourth quarter worth $4,057,682,000. Capital International Investors bought a new stake in Marsh & McLennan Companies during the fourth quarter worth $3,482,557,000. Capital World Investors lifted its stake in shares of Marsh & McLennan Companies by 0.5% in the 3rd quarter. Capital World Investors now owns 17,702,898 shares of the financial services provider’s stock valued at $3,567,410,000 after acquiring an additional 92,767 shares during the last quarter. Finally, Wellington Management Group LLP lifted its stake in shares of Marsh & McLennan Companies by 9.1% in the 3rd quarter. Wellington Management Group LLP now owns 15,091,478 shares of the financial services provider’s stock valued at $3,041,386,000 after acquiring an additional 1,260,434 shares during the last quarter. 87.99% of the stock is currently owned by institutional investors.

Insider Transactions at Marsh & McLennan Companies

In related news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This trade represents a 12.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by corporate insiders.

Marsh & McLennan Companies Stock Down 0.0%

Shares of NYSE:MRSH opened at $168.67 on Monday. The firm has a market cap of $81.49 billion, a P/E ratio of 21.08, a P/E/G ratio of 2.46 and a beta of 0.62. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. Marsh & McLennan Companies, Inc. has a 12-month low of $156.60 and a 12-month high of $220.32.

Marsh & McLennan Companies (NYSE:MRSH) last announced its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.21 by $0.08. The business had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The firm’s quarterly revenue was up 7.6% on a year-over-year basis. On average, analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently commented on MRSH shares. Piper Sandler dropped their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Morgan Stanley dropped their price target on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research note on Monday, April 6th. Weiss Ratings cut Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Bank of America dropped their price target on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research note on Tuesday, April 14th. Finally, Barclays reduced their target price on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Marsh & McLennan Companies has a consensus rating of “Hold” and an average target price of $200.19.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.